OptiBiotix Health PLC raised £1.5 million through the issuance of 2,419,355 new ordinary shares priced at 62 pence apiece.
Following the transaction, the company's issued share capital will increase to 82,905,067 ordinary shares.
The U.K.-based company will use the proceeds, along with existing funds, to capitalize on new growth opportunities including the development of its technology and products as well as building shareholder value.
OptiBiotix Health is a life sciences company focused on the development of microbiome modulators.
